Physician profile
Wasif M Abidi
NPI 1821230780
$43,353.58
in general payments reported to CMS, 2019-2025
28 companies · $2,939 in 2025
The $2,939 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,260 · 2020: $7,482 · 2021: $530 · 2022: $4,500 · 2023: $19K · 2024: $6,069 · 2025: $2,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $4,564 · Travel and Lodging: $2,704 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,812.82 |
| Food and Beverage | $4,564.40 |
| Travel and Lodging | $2,704.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $22,544.21 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Ambu INC. | $7,850.84 | 2020-2024 | |
| Boston Scientific Corporation | $3,365.59 | 2019-2025 | Overstitch Endoscopic Suturing System, Orise, Orbera Intragastric Balloon System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,647.74 | 2019-2025 | Xifaxan |
| Pentax of America, INC. | $2,026.59 | 2019 | |
| Abbvie INC. | $1,287.23 | 2019-2025 | Creon, Linzess, Mavyret |
| Conmed Corporation | $917.71 | 2020-2025 | Conmed Generators, Conmed Hemostasis, Conmed Dilation |
| Medtronic, INC. | $372.20 | 2024-2025 | Endoflip, Sharkcore, Prodigi |
| Olympus America INC. | $370.48 | 2019-2024 | Gastrointestinal Videoscope |
| Cook Medical LLC | $297.90 | 2019-2025 | Fusion, Hemospray |
| Fujifilm Healthcare Americas Corporation | $278.04 | 2023-2025 | Fujifilm |
| Takeda Pharmaceuticals U.S.A., INC. | $244.25 | 2024-2025 | Entyvio, Gattex |
| Intuitive Surgical, INC. | $152.12 | 2019 | |
| Erbe USA INC | $150.20 | 2019 | |
| Ethicon US, LLC | $124.83 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.83 | 2025 | Wegovy |
| Amgen INC. | $118.50 | 2025 | Uplizna |
| Aries Pharmaceuticals, INC. | $100.45 | 2019 | |
| Redhill Biopharma INC. | $69.10 | 2021-2022 | |
| Lumendi LLC | $51.61 | 2019 | |
| Endogastric Solutions, INC | $50.03 | 2022 | |
| Madrigal Pharmaceuticals | $44.94 | 2025 | Rezdiffra |
| Merck Sharp & Dohme LLC | $36.21 | 2023-2024 | Dificid |
| Regeneron Healthcare Solutions, INC. | $34.04 | 2024 | Dupixent |
| Janssen Biotech, INC. | $33.69 | 2025 | Tremfya |
| Alcresta Therapeutics, INC. | $25.00 | 2022 | |
| Romark Laboratories, Lc | $22.16 | 2019 | |
| Qol Medical, LLC | $16.09 | 2023 | Sucraid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wasif Abidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.